Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical performance of the LCx HCV RNA quantitative assay.

Journal of virological methods - 1 Feb 2005

Bertuzis Rasa, Hardie Alison, Hottentraeger Barbara, Izopet Jacques, Jilg Wolfgang, Kaesdorf Barbara, Leckie Gregor, Leete Jean, Perrin Luc, Qiu Chunfu, Ran Iris, Schneider George, Simmonds Peter, Robinson John

Abstract excerpt

This study was conducted to assess the performance of the Abbott laboratories LCx HCV RNA Quantitative Assay (LCx assay) in the clinical setting. Four clinical laboratories measured LCx assay precision, specificity, and linearity. In addition, a method comparison was conducted between the LCx assay and the Roche HCV Amplicor Monitor, version 2.0 (Roche Monitor 2.0) and the Bayer VERSANT HCV RNA 3.0 Assay (Bayer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Reference Standards

Share to RNA, Viral

Share to Sensitivity and Specificity

Share to Viremia

Share to Virology

Source

Identifiers

PMID: 15620399
DOI: 10.1016/j.jviromet.2004.09.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical performance of the LCx HCV RNA quantitative assay.PMID 15620399Read ↗

Performance attributes of the LCx HCV RNA quantitative assay.Semantic proximity Read ↗

Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.Semantic proximity Read ↗

Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA.Semantic proximity Read ↗

Performance characteristics of the COBAS AMPLICOR hepatitis C virus MONITOR Test, version 2.0.Semantic proximity Read ↗

Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent.Semantic proximity Read ↗

Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.Semantic proximity Read ↗

Comparative performance of two commercial sample-to-result systems for hepatitis C virus quantitation and genotyping.Semantic proximity Read ↗

Multicenter clinical evaluation of alinity m HCV assay performance.Semantic proximity Read ↗

Analytical performance of the VERIS MDx system HCV assay for detecting and quantifying HCV RNA.Semantic proximity Read ↗

Diagnosis and monitoring of HCV infection using the cobas® HCV test for use on the cobas® 6800/8800 systems.Semantic proximity Read ↗

Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.Semantic proximity Read ↗

Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.